Editorial Expression of Concern: RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells

Affiliations

¹ Department of Adult Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
² Northwestern University Medical School, Robert H Lurie Cancer Center, Chicago, IL, 60611, USA.
³ Division of Experimental Medicine and Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, MA, 02115, USA.
⁴ Department of Adult Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA. kenneth_anderson@dfci.harvard.edu.

Editorial

Dharminder Chauhan et al. Oncogene. 2024 Sep.

. 2024 Sep;43(40):3019.

doi: 10.1038/s41388-024-03152-8.

¹ Department of Adult Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
² Northwestern University Medical School, Robert H Lurie Cancer Center, Chicago, IL, 60611, USA.
³ Division of Experimental Medicine and Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, MA, 02115, USA.
⁴ Department of Adult Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA. kenneth_anderson@dfci.harvard.edu.

No abstract available

Expression of concern for

RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.
Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC. Chauhan D, et al. Oncogene. 1999 Nov 18;18(48):6733-40. doi: 10.1038/sj.onc.1203082. Oncogene. 1999. PMID: 10597281